GEN Exclusives

More »

GEN News Highlights

More »
Nov 3, 2009

Sigma-Aldrich Licenses Polyplus Transfection’s ZNA Oligos for Research Use

  • Sigma-Aldrich negotiated a worldwide license agreement to manufacture and commercialize Polyplus-transfection’s Zip Nucleic Acid (ZNA™) oligonucleotides for research applications. The company points out it will be the first to offer ZNA as custom DNA and RNA oligos to the life science industry.

    ZNA’s are oligonucleotides with attached cationic units. Polyplus claims the cationic residues increases the sensitivity of the oligos and results in increased affinity for nucleic acids without the loss of selectivity. Research applications of ZNAs include their use as PCR probes and primers, for in vitro miRNA detection and inhibition, and for siRNA applications.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?